Ramin Farzaneh-Far, Chief Medical Officer at Ra Pharmaceuticals, Inc. (RARX), sold 10,595 shares at $25.26 ($268K) on 2019-09-16, disclosed to the SEC on 2019-09-16.
Open-market sale of $268k RARX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RARX | SELL | 2020-01-16 | $995K | — | Filing → |
| RARX | SELL | 2019-12-18 | $1.0M | — | Filing → |
| RARX | SELL | 2019-12-18 | $500K | — | Filing → |